James A. Robinson Jr. Urovant Sciences Ltd. (UROV) insider trading activity

James A. Robinson Jr. is PEO;CEO/Urovant Sciences, Inc. of Urovant Sciences Ltd.. Currently has a direct ownership of 0 shares of UROV, which is worth approximately $0. The most recent transaction as insider was on Mar 29, 2021, when has been sold 8,385 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James A. Robinson Jr. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 29 2021	SELL Sale (or disposition) back to the issuer	-	8,385 Reduced 100.0%	0 Common Shares
Jan 10 2021	SELL Payment of exercise price or tax liability	$65,970 $16.11 p/Share	4,095 Reduced 32.81%	8,385 Common Shares

Also insider at

AGTC

APPLIED GENETIC TECHNOLOGIES CORP Healthcare

Director

URGN

UroGen Pharma Ltd. Healthcare

Director

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

Director

JAR